Trizivir

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2014
02420002014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
 
Is this relevant?
2008
2008
BACKGROUND Induction-maintenance strategies were associated with a low response rate. We compared the virological response with… (More)
Is this relevant?
2006
2006
OBJECTIVES To compare the lipid and metabolic effects, efficacy, and safety of twice-daily regimens of Trizivir (abacavir 300 mg… (More)
Is this relevant?
2005
2005
BACKGROUND Treatment failure during highly active antiretroviral therapy (HAART) is ultimately common and associated with the… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
2003
2003
OBJECTIVE To assess the antiviral efficacy, safety, and adherence in subjects who switched to Trizivir following long-term HIV-1… (More)
Is this relevant?
2003
2003
PURPOSE To analyze the evolution of clinical lipodystrophy (LD) and metabolic abnormalities in patients continuing to receive… (More)
Is this relevant?
2003
2003
Forty patients participating in the TRIZAL study were treated with a non-nucleoside reverse transcriptase inhibitor (NNRTI… (More)
Is this relevant?
Review
2002
Review
2002
Treatment of HIV infection has typically been carried out using two nucleoside analogues and a protease inhibitor (PI). Such… (More)
Is this relevant?
Review
2001
Review
2001
Treatment review is intended to inform and update nurses about treatments relevant to HIV/AIDS. Product information presented in… (More)
Is this relevant?
2000
2000
  • AIDS treatment news
  • 2000
New approval combines AZT, 3TC, and abacavir in one pill. 
Is this relevant?